Elon Musk Updates Twitter Bio To ‘Chief Twit’

https://twitter.com/elonmusk

Total
0
Shares
Related Posts
Read More

Reported Late Wednesday, Ardelyx Announces FDA Advisory Committee Votes 9-To-4 That The Benefits Of XPHOZAH Outweigh Its Risks For The Control Of Serum Phosphorus In Adult Patients With Chronic Kidney Disease On Dialysis

The Advisory Committee voted 9:4 in favor of XPHOZAH as a monotherapy and 10:2 in favor of XPHOZAH in combination with phosphate binders The Office of New Drugs is expected to provide a response to Ardelyx's appeal

ARDX